APOBEC3B and breast neoplasm: To test this hypothesis, we quantified APOBEC3B mRNA levels using reverse-transcriptase-quantitative PCR (RT-qPCR) in a large series of primary breast tumors and asked whether expression levels correlate with disease outcome.